Biomarkers of Sarcopenia and Sarcopenic Obesity in Renal Transplant Recipients: A Systematic Review and Evidence Quality Assessment
Ioanna Soukouli, Thomas Karagkounis, Konstantinos S Mylonas, Theofanis Kalathas, Kalliopi-Anna Poulia, Alexander Kokkinos, Smaragdi Marinaki, Chiara Lazzeri · 2025
Read Biomarkers of Sarcopenia and Sarcopenic Obesity in Renal Transplant Recipients: A Systematic Review and Evidence Quality Assessment by Ioanna Soukouli, Thomas Karagkounis, Konstantinos S Mylonas, Theofanis Kalathas, Kalliopi-Anna Poulia, Alexander Kokkinos, Smaragdi Marinaki, Chiara Lazzeri (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12734315.txt.
Description
A research team published a 2025 review of blood markers tied to muscle loss in people who have had a kidney transplant. Muscle loss, and muscle loss paired with excess fat, raise health risks after transplant, yet their body chemistry is still poorly mapped. The authors searched two large medical databases and judged each study with a standard quality tool.
Seven studies with 548 patients met the bar. One marker, myostatin, predicted muscle loss and tracked with grip strength and graft health. Other markers linked to fat, growth, and nerve support showed mixed ties to muscle mass. The team notes that these markers look promising but need more testing, and simple strength tests remain the most trusted tools for now.
Catalog record
| CREATOR | Ioanna Soukouli, Thomas Karagkounis, Konstantinos S Mylonas, Theofanis Kalathas, Kalliopi-Anna Poulia, Alexander Kokkinos, Smaragdi Marinaki, Chiara Lazzeri |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |